...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM - High Level Summary

Koo,

No I do not agree. Masila's trascript speaks for itself.

Best regards,

BearDownAZ

Share
New Message
Please login to post a reply